Experiment 782446

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

CYNAROSIDECHLOROGENIC ACID C,ISO:HYDROQUINONE,2-(3'-3'-DIMETHYL-ALLYL): 1-O-(4''-O-CAFFEOYL)-BETA-D-GLUCOPYRANOSYL:CHLOROGENIC ACID A,ISO: METHYL ESTERHYDROQUINONE,2-(3'-3'-DIMETHYL-ALLYL): 1-O-BETA-D-GLUCOSIDEHYDROQUINONE

Details

PropertyValue
Pharmacology
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Administration routeEXTERNAL
OrganismPhagnalon rupestre (ASTERACEAE)
CitationGONGORA,L: GINER,RM: MANEZ,S: RECIO,MC: RIOS,JL:. (2002). PHAGNALON RUPESTRE AS A SOURCE OF COMPOUNDS ACTIVE ON CONTACT HYPERSENSITIVITY.. 6(6)
Amount utilized
Compound isolated
DiseaseVS.DNFB INDUCED HYPERSENSITIVITY.
Dose amount0.5 MG
Number8
Qualitative resultACTIVE
AnimalMOUSE
Per unitEAR
Dose expressionCONC USED